Filing Flows › Elevance Health (ELV) › Q3 2026 › vs Q2 2026
Elevance Health (ELV) Q3 2026 vs Q2 2026 (quarter over quarter)
Elevance Health's revenue rose $955M (+2%) from $50.5B in Q2 2026 to $51.4B in Q3 2026. Operating margin 2.5% against 3.5% (-1.0 pts).
Elevance Health, Q3 2026: revenue $51.4B (+1% year over year), operating margin 2.5%, net earnings $1.3B, operating cash flow $1.3B. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 2.5% | 3.5% | -1.0 pts |
| Net margin | 2.6% | 2.9% | -0.3 pts |
| Free cash flow margin | 1.9% | 3.2% | -1.3 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $51.4B | $50.5B | $955M | +2% |
| Other income, net | $525M | $174M | $351M | +202% |
| Operating profit | $1.3B | $1.8B | −$494M | -28% |
| Costs & expenses | $50.2B | $48.7B | $1.4B | +3% |
| Pre-tax earnings | $1.8B | $1.9B | −$143M | -7% |
| Cost of revenue | $5.6B | $5.5B | $148M | +3% |
| SG&A | $5.8B | $5.5B | $205M | +4% |
| Other operating costs | $38.8B | $37.7B | $1.1B | +3% |
| Net earnings | $1.3B | $1.5B | −$111M | -8% |
| Income tax | $451M | $483M | −$32.0M | -7% |
| Depreciation & amortization | $363M | $366M | −$3.0M | -0.8% |
| Share-based compensation | $80.0M | $75.0M | $5.0M | +7% |
| Working capital & other | $519M | −$18.0M | $537M | — |
| Operating cash flow | $1.3B | $1.9B | −$646M | -34% |
| Free cash flow (OCF − capex) | $1.0B | $1.6B | −$626M | -38% |
| Capital expenditures | $267M | $287M | −$20.0M | -7% |
Questions
How much did Elevance Health's revenue grow quarter over quarter in Q3 2026?
Elevance Health's revenue rose $955M (+2%) from $50.5B in Q2 2026 to $51.4B in Q3 2026. Operating margin 2.5% against 3.5% (-1.0 pts).